Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics,Biotechnology and Applied Biochemistry

当前位置： X-MOL 学术 › Biotechnol. Appl. Bioc. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

Future developments in biosensors for field-ready SARS-CoV-2 virus diagnostics
Biotechnology and Applied Biochemistry ( IF 3.2 ) Pub Date : 2020-09-24 , DOI: 10.1002/bab.2033
Mona Fani ₁ , Milad Zandi ₂ , Saber Soltani ₂ , Samaneh Abbasi ₃

Affiliation

According to the evidence, the coronavirus disease 19 (COVID-19) is caused by a zoonotic pathogen named respiratory syndrome coronavirus 2 (SARS-CoV-2). This virus can spread through personal contact, respiratory droplets, and also through airborne transmission. A rapid, low-cost, and effective biosensor platform is essential to diagnose patients with COVID-19 infection, predominantly the asymptomatic individuals, and prevent the spread of the SARS-CoV-2 via transmission routes. The objective of this review is to provide a comparative view among current diagnostic methods, focusing on recently suggested biosensors for the detection of SARS-CoV2 in clinical samples. A capable SARS-CoV-2 biosensor can be designed by the holistic insights of various biosensor studies.

中文翻译：

用于现场 SARS-CoV-2 病毒诊断的生物传感器的未来发展

根据证据，冠状病毒病 19 (COVID-19) 是由一种名为呼吸综合征冠状病毒 2 (SARS-CoV-2) 的人畜共患病原体引起的。这种病毒可以通过个人接触、呼吸道飞沫传播，也可以通过空气传播。快速、低成本且有效的生物传感器平台对于诊断 COVID-19 感染患者（主要是无症状个体）并防止 SARS-CoV-2 通过传播途径传播至关重要。本次综述的目的是对当前的诊断方法进行比较，重点关注最近建议的用于检测临床样本中 SARS-CoV2 的生物传感器。可以通过各种生物传感器研究的整体见解来设计功能强大的 SARS-CoV-2 生物传感器。

更新日期：2020-09-24

点击分享查看原文

点击收藏

公开下载

阅读更多本刊最新论文本刊介绍/投稿指南11